Phosphorylation: new star of pathogenesis and treatment in steatotic liver disease

Area of Science:

• Biochemistry
• Hepatology
• Molecular Biology

Background:

• Steatotic liver disease is a major global health concern with unclear mechanisms and limited targeted treatments.
• Phosphorylation, a common protein modification, is implicated in steatotic liver disease but lacks systematic review.
• Existing research suggests phosphorylation influences molecule stability, localization, function, and interacts with other modifications.

Purpose of the Study:

• To systematically review the role of phosphorylation in steatotic liver disease.
• To elucidate phosphorylation-driven mechanisms underlying steatotic liver disease.
• To explore phosphorylation as a potential therapeutic target for steatotic liver disease.

Main Methods:

• Systematic literature review focusing on phosphorylation and steatotic liver disease.
• Analysis of studies investigating protein phosphorylation in liver fat accumulation.
• Identification of key signaling pathways involving phosphorylation in steatotic liver disease.

Main Results:

• Phosphorylation significantly impacts steatotic liver disease by regulating protein stability, localization, and function.
• Adenosine 5'-monophosphate-activated protein kinase (AMPK), AKT, and NF-kB pathways are central to steatotic liver disease pathogenesis via phosphorylation.
• Interventions like lifestyle changes and medications can modulate phosphorylation to alleviate steatotic liver disease symptoms.

Conclusions:

• Phosphorylation is a critical mechanism in the development and progression of steatotic liver disease.
• Targeting specific phosphorylation events presents a novel therapeutic avenue for steatotic liver disease.
• Further research into phosphorylation's role could unlock new treatments for this prevalent liver disease.